Comparing Barriers and Facilitators to Adolescent and Young Adult Clinical Trial Enrollment Across High- and Low-Enrolling Community-Based Clinics. (7th March 2022)

• Record Type: Journal Article
• Authors: Siembida, Elizabeth J; Loomans-Kropp, Holli A; Tami-Maury, Irene; Freyer, David R; Sung, Lillian; Crosswell, Howland E; Pollock, Brad H; Roth, Michael E
• Is Part Of: Oncologist. Volume 27:Number 5(2022)
• Page Start: 363
• Page End: 370
• Publication Date: 2022-03-07
• Subjects: adolescent and young adult -- clinical trial enrollment -- barriers -- facilitators -- NCORP; Oncology -- Periodicals; Tumors -- Periodicals; Cancérologie -- Périodiques; Tumeurs -- Périodiques; Oncology; Tumors; Neoplasms; Electronic journals; Periodicals; Periodicals; 616.994
• DOI: 10.1093/oncolo/oyac030
• Languages: English
• ISSNs: 1083-7159

Abstract

Abstract : Adolescent and young adults with cancer enroll onto cancer clinical trials at lower rates than those with childhood cancer and rates similar to older adults with cancer. This article examines the patterns of barriers and facilitators between high- and low-enrolling community-based clinics to identify targets for intervention. Abstract: Background: Adolescent and young adult (AYA) patients with cancer are underrepresented on cancer clinical trials (CCTs), and most AYAs are treated in the community setting. Past research has focused on individual academic institutions, but factors impacting enrollment vary across institutions. Therefore, we examined the patterns of barriers and facilitators between high- and low-AYA enrolling community-based clinics to identify targets for intervention. Materials and Methods: We conducted 34 semi-structured interviews with stakeholders employed used at National Cancer Institute Community Oncology Research Program (NCORP) affiliate sites ("clinics"). Stakeholders (eg, clinical research associates, patient advocates) were recruited from high- and low-AYA enrolling clinics. We conducted a content analysis and calculated the percentage of stakeholders from each clinic type that reported the barrier or facilitator. A 10% gap between high- and low-enrollers was considered the threshold for differences. Results: Both high- and low-enrollers highlighted insufficient resources as a barrier and the presence of a patient eligibility screening process as a facilitator to AYA enrollment. High-enrolling clinics reported physician gatekeeping as a barrier and the improvement of departmental collaboration as a facilitator. Low-enrollers reported AYAs' uncertainty regarding the CCT process as a barrier and the need for increased physician endorsement of CCTs as a facilitator. Conclusions: High-enrolling clinics reported more barriers downstream in the enrollment process, such as physician gatekeeping. In contrast, low-enrolling clinics struggled with the earlier steps in the CCT enrollment process, such as identifying eligible trials. These findings highlight the need for multi-level, tailored interventions rather than a "one-size-fits-all" approach to improve AYA enrollment in the community setting.